The Enterprise Value as of June 2026 (TTM) for Alpine Immune Sciences, Inc. (ALPN) is 4.42B

According to Alpine Immune Sciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.42B. This represents a change of 276.94% compared to the average of 1.17B of the last 4 quarters.

Alpine Immune Sciences, Inc. (ALPN) Historical Enterprise Value (quarterly & annually)

How has ALPN Enterprise Value performed in the past?

The mean historical Enterprise Value of Alpine Immune Sciences, Inc. over the last ten years is 207.15M. The current 4.42B Enterprise Value has changed 213.40% with respect to the historical average. Over the past ten years (40 quarters), ALPN's Enterprise Value was at its highest in in the March 2024 quarter at 2.55B. The Enterprise Value was at its lowest in in the June 2015 quarter at -37512150.00.

Alpine Immune Sciences, Inc. (ALPN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Alpine Immune Sciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alpine Immune Sciences, Inc. (ALPN) Average Enterprise Value

How has ALPN Enterprise Value performed in the past?

The current Enterprise Value of Alpine Immune Sciences, Inc. (ALPN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Alpine Immune Sciences, Inc. (ALPN) Enterprise Value vs. Peers

How is ALPN’s Enterprise Value compared to its peers?

Alpine Immune Sciences, Inc.’s Enterprise Value is greater than Global Blood Therapeutics, Inc. (-25100000.00), greater than RayzeBio, Inc. Common Stock (3.63B), greater than Mirati Therapeutics, Inc. (3.93B), greater than Churchill Capital Corp XI (428.21M), greater than CymaBay Therapeutics, Inc. (3.64B), greater than Turning Point Therapeutics, Inc. (-422300000.00), greater than SpringWorks Therapeutics, Inc. (3.48B), less than Ascentage Pharma Group International (10.49B), less than IVERIC bio, Inc. (5.13B), less than Reata Pharmaceuticals, Inc. (6.64B),

Build a custom stock screener for Alpine Immune Sciences, Inc. (ALPN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alpine Immune Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alpine Immune Sciences, Inc. (ALPN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alpine Immune Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.